SEC Form 4 · accession 0001225208-15-005006
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Pierce
Officer — SVP and President, Endoscopy
Period of report
Feb 18, 2015
Accepted (ET)
Feb 20, 2015 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 18, 2015 | M | 8,500 | $8.30 | A | 40,119 | D | |
| Common Stock | Feb 18, 2015 | S | 8,500 | $16.4701 | D | 31,619 | D | |
| Common Stock | Feb 19, 2015 | S | 3,458 | $16.4441 | D | 28,161 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $8.30 | Feb 18, 2015 | M | 8,500 | D | — | Feb 24, 2019 | Common Stock | 8,500 | 25,012 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Grant to the reporting person of an option to purchase 33,512 shares of common stock vesting in four equal annual installments beginning on February 24, 2010, the first anniversary of the grant.